Strategies towards improving the pharmacokinetic profile of ε-substituted lysinol-derived HIV protease inhibitors

MeSH terms

• Antiretroviral Therapy, Highly Active
• HIV Infections / drug therapy
• HIV Protease Inhibitors / chemistry
• HIV Protease Inhibitors / pharmacokinetics*
• HIV Protease Inhibitors / therapeutic use
• Lysine / chemistry*
• Structure-Activity Relationship